Therefore, we concluded that SD70-induced KDM4C inhibition increases the CXCL10 transcriptional level to mediate the increased intratumoral infiltration and activation of CD8+ T cells, which in turn enhances the efficacy of our triple therapy in lung cancer. The gene discussed is CXCL10; the disease is lung carcinoma.